Barbara Lopez Kunz's Insider Trades & SAST Disclosures
Barbara Lopez Kunz's most recent trade in Aptevo Therapeutics Inc was a trade of 925 Restricted Stock Unit done . Disclosure was reported to the exchange on July 17, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Barbara Lopez Kunz.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jul 2024 | 925 | 925 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 0 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 81 | 198 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 117 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2024 | 7 | 0 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 0 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2023 | 3,571 | 4,880 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2023 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 1,309 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2023 | 297 | 298 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Aug 2022 | 3,571 | 3,571 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 595 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 298 | 1,012 (0%) | 0% | - | Common Stock | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 2,678 | 2,678 | - | - | Stock Option (right to buy) | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 893 | 893 | - | - | Restricted Stock Unit | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,785 | 0 | - | - | Stock Option (right to buy) | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 1,339 | 0 | - | - | Stock Option (right to buy) | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 1,322 | 1,322 | - | - | Stock Option (right to buy) | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 27 Jul 2020 | 892 | 0 | - | - | Stock Option (right to buy) | |
| Aptevo Therapeutics Inc | Barbara Lopez Kunz | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jul 2020 | 170 | 170 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges